Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. (Q50952629)
Jump to navigation
Jump to search
scientific article published on 13 July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. |
scientific article published on 13 July 2015 |
Statements
1 reference
Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. (English)
1 reference
1 reference
Tong-Yan Liu
1 reference
Chang-Xiang Shi
1 reference
Run Gao
1 reference
Hai-Jian Sun
1 reference
Xiao-Qing Xiong
1 reference
Lei Ding
1 reference
Qi Chen
1 reference
Yue-Hua Li
1 reference
Jue-Jin Wang
1 reference
Yu-Ming Kang
1 reference
13 July 2015
1 reference
1 reference
129
1 reference
10
1 reference
839-850
1 reference
Identifiers
1 reference
1 reference